# Velan Capital Investment Management 13F Q2 2026

Velan Capital Investment Management LP reported $164 million in 13F securities across 51 positions for the quarter ended June 30, 2026, in a holdings report filed August 14, 2026. Its largest holding was Praxis Precision Medicines I at $29.7 million, 18.1% of the reported value. Since Q1 2026 it opened 7 new positions and exited 5.

SpecStream is the live web data engine for teams and agents. It reads the SEC's Form 13F data sets each quarter, and this page is that reading, keyed on the manager's CIK and the security's CUSIP. Ask for the managers or the holdings you track, and each new 13F filing arrives in your sheet, CRM, Slack or agent as the SEC publishes it.

- Quarter: Q2 2026, the quarter ended June 30, 2026
- Reported value: $164,207,527
- Positions: 51
- Filed: August 14, 2026
- Report type: 13F holdings report
- CIK: 1848809
- Form 13F file number: 028-21996
- CRD number: 310732
- Business address: 100 North Main Street Suite 301, Alpharetta, GA 30009
- SEC filing: [0001848809-26-000003](https://www.sec.gov/Archives/edgar/data/1848809/000184880926000003/0001848809-26-000003-index.htm)

## Top 25 holdings by value

The largest of 51 positions by reported value at the end of the quarter ended June 30, 2026. Put and call options are marked in the class. Change is in shares or principal against the filing for the quarter ended March 31, 2026.

| Issuer | Class | Shares or principal | Value | Change since Q1 2026 |
| --- | --- | --- | --- | --- |
| [Praxis Precision Medicines I](https://specstream.ai/data/institutional-holders/praxis-precision-medicines-i-74006w207) | COM NEW | 88,781 | $29.7 million | -12,000 |
| [Maplight Therapeutics Inc](https://specstream.ai/data/institutional-holders/maplight-therapeutics-inc-56565p103) | COM | 492,893 | $17.7 million | No change |
| [Sutro Biopharma Inc](https://specstream.ai/data/institutional-holders/sutro-biopharma-inc-869367201) | COM SHS | 512,160 | $17 million | No change |
| [Immix Biopharma Inc](https://specstream.ai/data/institutional-holders/immix-biopharma-inc-45258h106) | COM | 1,085,000 | $11.2 million | +345,000 |
| [Protara Therapeutics Inc](https://specstream.ai/data/institutional-holders/protara-therapeutics-inc-74365u107) | COM STK | 2,844,652 | $10.9 million | +10,000 |
| [Abivax SA](https://specstream.ai/data/institutional-holders/abivax-sa-00370m103) | SPONSORED ADS | 65,630 | $8.7 million | -11,370 |
| [Tenax Therapeutics Inc](https://specstream.ai/data/institutional-holders/tenax-therapeutics-inc-88032l605) | COM NEW | 549,985 | $8 million | -33,348 |
| [Anteris Technologies Global](https://specstream.ai/data/institutional-holders/anteris-technologies-global-03675p102) | COM | 700,000 | $6.9 million | No change |
| [Edesa Biotech Inc](https://specstream.ai/data/institutional-holders/edesa-biotech-inc-27966l306) | COM NEW | 827,500 | $6.7 million | No change |
| [Evommune Inc](https://specstream.ai/data/institutional-holders/evommune-inc-30054y107) | COM SHS | 451,255 | $6 million | +5,000 |
| [Avalo Therapeutics Inc](https://specstream.ai/data/institutional-holders/avalo-therapeutics-inc-05338f306) | COM NEW | 324,452 | $6 million | +139,330 |
| [Xencor Inc](https://specstream.ai/data/institutional-holders/xencor-inc-98401f105) | COM | 255,000 | $4.1 million | +5,000 |
| [Rezolute Inc](https://specstream.ai/data/institutional-holders/rezolute-inc-76200l309) | COM NEW | 750,000 | $3.9 million | No change |
| [Heron Therapeutics Inc](https://specstream.ai/data/institutional-holders/heron-therapeutics-inc-427746102) | COM | 8,753,290 | $3.7 million | No change |
| [Verrica Pharmaceuticals Inc](https://specstream.ai/data/institutional-holders/verrica-pharmaceuticals-inc-92511w207) | COM SHS | 471,559 | $2.9 million | No change |
| [C4 Therapeutics Inc](https://specstream.ai/data/institutional-holders/c4-therapeutics-inc-12529r107) | COM STK | 570,000 | $2.7 million | New |
| [Eupraxia Pharmaceuticals Inc](https://specstream.ai/data/institutional-holders/eupraxia-pharmaceuticals-inc-29842p105) | COM | 352,000 | $2.3 million | No change |
| [Adma Biologics Inc](https://specstream.ai/data/institutional-holders/adma-biologics-inc-000899104) | COM | 250,000 | $2.1 million | New |
| [Rein Therapeutics Inc](https://specstream.ai/data/institutional-holders/rein-therapeutics-inc-00887a204) | COM NEW | 1,700,000 | $1.8 million | New |
| [Lyell Immunopharma Inc](https://specstream.ai/data/institutional-holders/lyell-immunopharma-inc-55083r203) | COM NEW | 105,000 | $1.5 million | +3,000 |
| Nasus Pharma LTD | ORD SHS | 359,390 | $1.3 million | No change |
| [Profound Med Corp](https://specstream.ai/data/institutional-holders/profound-med-corp-74319b502) | COM NEW | 170,278 | $1.1 million | -115,432 |
| [Jasper Therapeutics Inc](https://specstream.ai/data/institutional-holders/jasper-therapeutics-inc-471871202) | COM NEW | 2,668,395 | $1.1 million | No change |
| Tenax Therapeutics Inc | COM NEW (call) | 68,700 | $999,585 | New |
| [Protagonist Therapeutics Inc](https://specstream.ai/data/institutional-holders/protagonist-therapeutics-inc-74366e102) | COM | 3,700 | $453,546 | No change |

## New positions in Q2 2026

7 positions not in the filing for the quarter ended March 31, 2026.

| Issuer | Class | Shares or principal | Value |
| --- | --- | --- | --- |
| [C4 Therapeutics Inc](https://specstream.ai/data/institutional-holders/c4-therapeutics-inc-12529r107) | COM STK | 570,000 | $2.7 million |
| [Adma Biologics Inc](https://specstream.ai/data/institutional-holders/adma-biologics-inc-000899104) | COM | 250,000 | $2.1 million |
| [Rein Therapeutics Inc](https://specstream.ai/data/institutional-holders/rein-therapeutics-inc-00887a204) | COM NEW | 1,700,000 | $1.8 million |
| Tenax Therapeutics Inc | COM NEW (call) | 68,700 | $999,585 |
| [Tectonic Therapeutic Inc](https://specstream.ai/data/institutional-holders/tectonic-therapeutic-inc-878972108) | COM | 6,000 | $206,250 |
| [An2 Therapeutics Inc](https://specstream.ai/data/institutional-holders/an2-therapeutics-inc-037326105) | COM | 40,000 | $193,600 |
| [Scynexis Inc](https://specstream.ai/data/institutional-holders/scynexis-inc-811292309) | COM | 40,000 | $162,800 |

## Positions exited in Q2 2026

5 positions in the filing for the quarter ended March 31, 2026 and not in this one, with the shares and value reported then.

| Issuer | Class | Shares or principal | Value |
| --- | --- | --- | --- |
| [Esperion Therapeutics Inc Ne](https://specstream.ai/data/institutional-holders/esperion-therapeutics-inc-ne-29664w105) | COM | 1,720,000 | $4.7 million |
| [Kazia Therapeutics LTD](https://specstream.ai/data/institutional-holders/kazia-therapeutics-ltd-48669g303) | SPONSORED ADS | 135,315 | $1 million |
| [Arrowhead Pharmaceuticals in](https://specstream.ai/data/institutional-holders/arrowhead-pharmaceuticals-in-04280a100) | COM | 6,500 | $407,550 |
| [Design Therapeutics Inc](https://specstream.ai/data/institutional-holders/design-therapeutics-inc-25056l103) | COM | 20,000 | $212,800 |
| [PMV Pharmaceuticals Inc](https://specstream.ai/data/institutional-holders/pmv-pharmaceuticals-inc-69353y103) | COM | 73,000 | $90,520 |

## Also on SpecStream

- [Velan Capital Investment Management LP Form 13F filing on EDGAR](https://www.sec.gov/Archives/edgar/data/1848809/000184880926000003/0001848809-26-000003-index.htm)
- [Largest 13F filers in Georgia](https://specstream.ai/data/institutional-holdings/state/georgia)
- [Largest institutional managers by 13F value](https://specstream.ai/data/institutional-holdings)
- [Most widely held securities in 13F filings](https://specstream.ai/data/institutional-holders)

Source: [the SEC's Form 13F data sets](https://www.sec.gov/data-research/sec-markets-data/form-13f-data-sets). Public data published by the US Securities and Exchange Commission (US government work). Managers report these holdings themselves in Form 13F, and the SEC does not check or guarantee them. Form 13F lists long positions in US listed equities, some options and convertible notes held at the end of the quarter, and leaves out short positions, cash, most bonds and holdings below the reporting threshold. Values are market values in US dollars as the manager filed them. A manager can ask the SEC to keep some positions confidential for a time. This page uses SEC data and is not endorsed or certified by the SEC.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in Alpharetta, Georgia

- [Hotels in Alpharetta, Georgia](https://specstream.ai/data/businesses/hotels/alpharetta-georgia-united-states)
- [Mortgage brokers in Alpharetta, Georgia](https://specstream.ai/data/businesses/mortgage-brokers/alpharetta-georgia-united-states)
- [Public health clinics in Alpharetta, Georgia](https://specstream.ai/data/businesses/public-health-clinics/alpharetta-georgia-united-states)
- [Contractors in Alpharetta, Georgia](https://specstream.ai/data/businesses/contractors/alpharetta-georgia-united-states)
- [Indian restaurants in Alpharetta, Georgia](https://specstream.ai/data/businesses/indian-restaurants/alpharetta-georgia-united-states)
- [Obstetrics and gynecology practices in Alpharetta, Georgia](https://specstream.ai/data/businesses/obstetrics-and-gynecology-practices/alpharetta-georgia-united-states)
